David M. Waterhouse, MD, MPH, is a medical oncologist and hematologist with Oncology Hematology Care (OHC) in Cincinnati, Ohio. Dr. Waterhouse’s specialties are lunch cancer and urologic cancer. He is the founder and co-director of OHC’s nationally recognized Clinical Research Program and a former strategic partner in the Sarah Cannon Research Network. He is currently a national network principal investigator for The US Oncology Network and US Oncology Research and is a member of its Research Executive Committee and an associate director of the Lung Cancer Committee. He is also active within US Oncology’s HOER program.
Dr. Waterhouse is the recipient of numerous recognitions, including the US Oncology’s inaugural Culture of Research Award (2020), Oncology Time’s Excellence in Oncology Award (2019), The US Oncology Network’s Excellence in Clinical Research Award (2017), Cancer Support Community Inspiration in Cancer Award (2016), Cincinnati Health Care Hero (Innovation) award (2016) and is a two-time winner of ASCO’s Clinical Trials Participation Award (2015, 2007). Dr. Waterhouse is a former ASCO Young Investigator and past-chair of the ASCO Research Community Forum. He is also a former member of ASCO’s Cancer Research Committee.
Dr. Waterhouse received his medical degree from the University of Massachusetts. He completed a fellowship in medical oncology and hematology at the University of Michigan in Ann Arbor, where he also earned a master’s degree in public health.
